Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
Journal of gastroenterology and hepatology | 2018-08-01 | PMID 29346834
Kao Jia-Horng, Yu Min-Lung, Chen Chi-Yi and 5 more
